Medicines Company to Acquire Incline Therapeutics Anesthesia Device Company for $185M

Medicines Company, a drug maker for hospitals, will spend $300 million to increase its surgical product portfolio, according to Reuters.

The expenditure includes two deals, including one for $185 million to acquire Incline Therapeutics, a company developing a device to manage post-operative pain.

The other deal is for $105 million for a two-year license to market Bristol-Myers Squibb's device to control surgical bleeding.

Incline's patient-controlled analgesia system called IONSYS is for short-term management of acute post-operative pain.

More Articles on Anesthesia:
Anesthesia Machine Sales Expected to Increase by 2014
FDA Does Not Approve Zogenix's Zohydro Opioid Pain Medication
Dr. Brett Anderson Named Heritage Valley Chair of Anesthesiology


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars